Investor Series: Opportunities in the Cell and Gene Therapy Market (Focus on Need for Cell and Gene Therapies, Landscape of Key Innovators, Analysis of Product Offerings and Affiliated Value Propositions, Insights from Historical Funding Activity, Startup Health Indexing and Company Valuation Analysis, Financial Analysis of Key Public Ventures, Market Forecast and Opportunity Analysis, Insights from Publicly Disclosed Investor Exits and Key Acquisition Targets)